Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes is a research paper published in Journal of Diabetes Research (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NS081082
National Institutes of Health
Grant: NS103703
National Institutes of Health
Grant: AG039736
National Institutes of Health
Grant: 5R44NS103703-02
Development of NSI-189, a novel neurogenic molecule, to prevent and treat diabetic neuropathy
National Institutes of Health
Grant: 5R01AG039736-03
Comorbidity of Alzheimer's disease and Diabetes: pathologic mechanism and therapy
National Institutes of Health
Grant: 1R01NS081082-01A1
Cholinergic constraint and diabetic neuropathy
FWCI
0.99
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals